Erythropoietin does not affect TNF and IL-6 production directly.
The tissue-protective action of erythropoietin (EPO) in animal models is often associated with reduced inflammation. However, there are many contrasting reports of the effect of EPO on the production of inflammatory cytokines induced by lipopolysaccharide (LPS) in vitro, with different papers report...
Main Authors: | Cervellini, I, Sacre, S, Ghezzi, P, Mengozzi, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2013
|
Registos relacionados
-
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
Por: Cervellini, I, et al.
Publicado em: (2013) -
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
Por: Cervellini, I, et al.
Publicado em: (2013) -
Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor
Por: Ilaria Cervellini, et al.
Publicado em: (2013-06-01) -
Therapeutic efficacy of erythrpoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis
Por: Cervellini, I, et al.
Publicado em: (2013) -
Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis.
Por: Mengozzi, M, et al.
Publicado em: (2008)